Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

453 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Omalizumab management beyond clinical trials: the added value of a network model.
Caminati M, Senna G, Chieco Bianchi F, Marchi MR, Vianello A, Micheletto C, Pomari C, Tognella S, Savoia F, Mirisola V, Rossi A; NEONET Study Group. Caminati M, et al. Among authors: vianello a. Pulm Pharmacol Ther. 2014 Oct;29(1):74-9. doi: 10.1016/j.pupt.2014.01.007. Epub 2014 Feb 6. Pulm Pharmacol Ther. 2014. PMID: 24508951
Health and social impacts of COPD and the problem of under-diagnosis.
Carlone S, Balbi B, Bezzi M, Brunori M, Calabro S, Foschino Barbaro MP, Micheletto C, Privitera S, Torchio R, Schino P, Vianello A. Carlone S, et al. Among authors: vianello a. Multidiscip Respir Med. 2014 Dec 6;9(1):63. doi: 10.1186/2049-6958-9-63. eCollection 2014. Multidiscip Respir Med. 2014. PMID: 25699180 Free PMC article. Review.
Drop-out rate among patients treated with omalizumab for severe asthma: Literature review and real-life experience.
Caminati M, Senna G, Stefanizzi G, Bellamoli R, Longhi S, Chieco-Bianchi F, Guarnieri G, Tognella S, Olivieri M, Micheletto C, Festi G, Bertocco E, Mazza M, Rossi A, Vianello A; North East Omalizumab Network study group. Caminati M, et al. Among authors: vianello a. BMC Pulm Med. 2016 Aug 25;16(1):128. doi: 10.1186/s12890-016-0290-5. BMC Pulm Med. 2016. PMID: 27562427 Free PMC article. Review.
Fatal asthma; is it still an epidemic?
Vianello A, Caminati M, Crivellaro M, El Mazloum R, Snenghi R, Schiappoli M, Dama A, Rossi A, Festi G, Marchi MR, Bovo C, Canonica GW, Senna G. Vianello A, et al. World Allergy Organ J. 2016 Dec 14;9(1):42. doi: 10.1186/s40413-016-0129-9. eCollection 2016. World Allergy Organ J. 2016. PMID: 28031774 Free PMC article.
Thunderstorm Asthma: A Critical Appraisal Based on Clinical Practice.
Caminati M, Senna G, Vianello A, Ricci G, Bellamoli R, Longhi S, Crivellaro M, Marcer G, Monai M, Passalacqua G. Caminati M, et al. Among authors: vianello a. J Investig Allergol Clin Immunol. 2018 Aug;28(4):273-275. doi: 10.18176/jiaci.0259. J Investig Allergol Clin Immunol. 2018. PMID: 30073965 Free article. No abstract available.
Relevance of TH2 Markers in the Assessment and Therapeutic Management of Severe Allergic Asthma: A Real-Life Perspective.
Caminati M, Vianello A, Chieco Bianchi F, Festi G, Guarnieri G, Marchi MR, Micheletto C, Olivieri M, Tognella S, Guerriero M, Senna G; NEONET Study Group. Caminati M, et al. Among authors: vianello a. J Investig Allergol Clin Immunol. 2020;30(1):35-41. doi: 10.18176/jiaci.0379. Epub 2019 Jan 24. J Investig Allergol Clin Immunol. 2020. PMID: 30676321 Free article.
Higher blood eosinophil levels after omalizumab treatment may be associated with poorer asthma outcomes.
Sposato B, Scalese M, Milanese M, Masieri S, Cavaliere C, Latorre M, Scichilone N, Ricci A, Cresti A, Santus P, Olivieri C, Perrella A, Rogliani P, Paggiaro P; Omalizumab Italian Study Group. Sposato B, et al. J Allergy Clin Immunol Pract. 2019 May-Jun;7(5):1643-1646. doi: 10.1016/j.jaip.2019.03.006. Epub 2019 Mar 19. J Allergy Clin Immunol Pract. 2019. PMID: 30898690 No abstract available.
453 results